Inactive Instrument
CEREP Share Price Euronext Paris
Stocks
FR0004042232
Biotechnology & Medical Research
|
End-of-day quote
Euronext Paris
|
||
| - EUR | - |
|
| 08-25 | Lotus Bakeries, the most expensive speculoos on the (stock) market in Europe |  |
| 04-29 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 91.8M 106M 86.63M 78.59M 147M 10.15B 149M 1.03B 399M 5.15B 398M 389M 16.38B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 70.77M 81.67M 66.78M 60.59M 114M 7.83B 114M 798M 307M 3.97B 307M 300M 12.62B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 10/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 10/08/2023 |
Damien Vielliard
BRD | Director/Board Member | - | 22/05/2024 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.56% | -4.71% | -2.38% | +9.18% | 45.48B | |
| +0.44% | -1.49% | +342.04% | +527.41% | 43.68B | |
| +1.80% | +2.77% | +43.24% | +25.08% | 43.09B | |
| +2.35% | +0.97% | +6.81% | +78.79% | 39.4B | |
| +0.34% | -4.94% | +9.34% | +40.23% | 31.91B | |
| -0.56% | -2.86% | - | - | 17.31B | |
| +1.18% | +0.67% | +19.84% | +112.43% | 16.4B | |
| +2.07% | +0.78% | +14.39% | +30.91% | 14.24B | |
| -1.34% | -2.57% | +79.67% | +31.66% | 13.28B | |
| Average | +0.82% | -2.97% | +64.12% | +106.96% | 29.42B | |
| Weighted average by Cap. | +1.03% | -3.26% | +76.17% | +127.79% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 46.73M 38.21M 34.66M 65.02M 4.48B 65.5M 456M 176M 2.27B 175M 172M 7.22B | 41.1M 47.43M 38.79M 35.19M 66.01M 4.55B 66.48M 463M 178M 2.31B 178M 174M 7.33B |
| Net income | 7.15M 8.26M 6.75M 6.13M 11.49M 791M 11.57M 80.64M 31.07M 401M 31.01M 30.33M 1.28B | 4.78M 5.52M 4.51M 4.09M 7.68M 529M 7.74M 53.9M 20.77M 268M 20.73M 20.27M 853M |
| Net Debt | -17.25M -19.91M -16.28M -14.77M -27.71M -1.91B -27.91M -194M -74.93M -968M -74.78M -73.14M -3.08B | -21.03M -24.28M -19.85M -18.01M -33.78M -2.33B -34.03M -237M -91.35M -1.18B -91.18M -89.17M -3.75B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
